Pharmacological treatments for ADHD and the novel agent atomoxetine.

作者信息

Bailey Katharine P

机构信息

Yale University School of Nursing, New Haven, Connecticut, USA.

出版信息

J Psychosoc Nurs Ment Health Serv. 2003 Aug;41(8):12-7.

PMID:13677007

Abstract

摘要

相似文献

Pharmacological treatments for ADHD and the novel agent atomoxetine.

J Psychosoc Nurs Ment Health Serv. 2003 Aug;41(8):12-7.

Atomoxetine (strattera) for ADHD.

Med Lett Drugs Ther. 2003 Feb 3;45(1149):11-2.

Atomoxetine for attention deficit/hyperactivity disorder.

Issues Emerg Health Technol. 2003 May(46):1-4.

[Atomoxetine for the treatment of attention-deficit/hyperactivity disorder].

Fortschr Neurol Psychiatr. 2004 Oct;72(10):586-91. doi: 10.1055/s-2004-830049.

Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder.

Arch Dis Child. 2005 Feb;90 Suppl 1(Suppl 1):i26-9. doi: 10.1136/adc.2004.059386.

Safety profile of atomoxetine in the treatment of children and adolescents with ADHD.

J Clin Psychiatry. 2002;63 Suppl 12:50-5.

Increased blood pressure and atomoxetine.

J Am Acad Child Adolesc Psychiatry. 2005 Jun;44(6):510. doi: 10.1097/01.chi.0000159164.72119.15.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Clin Ther. 2007 Jun;29(6):1168-77. doi: 10.1016/j.clinthera.2007.06.017.

A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.

Clin Ther. 2006 Feb;28(2):280-93. doi: 10.1016/j.clinthera.2006.02.008.

Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment.

J Clin Psychopharmacol. 2004 Feb;24(1):30-5. doi: 10.1097/01.jcp.0000104907.75206.c2.

引用本文的文献

Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system.

Front Pharmacol. 2023 Aug 14;14:1208456. doi: 10.3389/fphar.2023.1208456. eCollection 2023.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验